Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 8 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
71 38.8 months Advanced breast cancer 5 Biologic therapy
Chemotherapy
Rigshospitalet Denmark 1/2011
Treatment Details: Patients: This phase 3 study involved women with advanced breast cancer (genetically HER2-positive) who were divided into two separate treatment groups. Group A consisted of 143 patients w
 
72 38.4 months Malignant peritoneal mesothelioma 5 Chemotherapy
Surgery
University of Maryland School of Medicine United States 3/2013
Treatment Details: Patients: This study involved 211 malignant peritoneal mesothelioma patients with a median age of 52 years and 38.9% were male. Treatment: Patients were treated with cytoreductive surge
 
73 38.2 months Postmenopausal breast cancer 5 Hormone
Karolinska Institutet and University Hospital Sweden 6/2012
Treatment Details: Patients: This phase 3 study involved women with receptor-positive postmenopausal breast cancer who were divided into two separate treatment groups. Group A consisted of 258 patients with
 
74 37.9 months Castration-Resistant Prostate Cancer 5 Biologic therapy
Massachusetts General Hospital Cancer Center United States 4/2014
Treatment Details: Patients: This phase 3 study involved 323 castration- resistant prostate cancer patients with bone metastases and a median age of 66.1 years. Treatment: Patients received zoledronic aci
 
75 37.8 months Postmenopausal breast cancer 5 Hormone
Karolinska Institutet and University Hospital Sweden 6/2012
Treatment Details: Patients: This phase 3 study involved women with receptor-positive postmenopausal breast cancer who were divided into two separate treatment groups. Group A consisted of 258 patients with
 
76 37.8 months Follicular lymphoma 5 Biologic therapy
University of Bologna Italy 10/2012
Treatment Details: Patients: This phase 3 study involved follicular lymphoma patients who were divided into two separate treatment groups. Group A consisted of 103 patients with a median age of 61 years and
 
77 37.5 months Advanced epithelial ovarian cancer 4 Chemotherapy
Surgery
Instituto do Cancer do Estado de São Paulo Brazil 2/2014
Treatment Details: Patients: This study involved 656 female patients with advanced epithelial ovarian cancer, tubal carcinoma, or primary peritoneal cancer. The median patient age was 60 years. Treatment:
 
78 37.4 months Advanced ovarian cancer or primary peritoneal cancer 4 Chemotherapy
Immunotherapy
Arizona Cancer Center United States 5/2008
Treatment Details: Patients: This phase 3 trial involved 847 women. The majority (774) had ovarian cancer, and 73 had primary peritoneal cancer. The median age was 56, ranging from 18 to 85 years of age.
 
79 37.0 months Hepatocellular carcinoma 5 Chemotherapy
Radiation
Qilu Hospital, Shandong University China 4/2008
Treatment Details: Patients: This study involved 291 patients with hepatocellular carcinoma (liver cancer). The majority of patients were men, and the average age of these patients was 63 years old. Treatm
 
80 37.0 months Ovarian cancer or fallopian tube, or primary peritoneal cancer 4 Biologic therapy
Chemotherapy
University of Queensland Australia 5/2008
Treatment Details: Patients: This phase Ib study involved 48 women with epithelial ovarian, fallopian tube, or primary peritoneal cancer. They ranged in age from 32.4 to 68.7 years of age. Treatment: Pat
 
Page 8 of 187  | Previous Page  | Next Page